Abstract
complexity of the pathophysiology of these diseases, NDD and AD are also particularly difficult 5 to treat due to the limited permeability of the blood-brain barrier (BBB). Indeed, the BBB is very 6 efficient to prevent the entry of foreign compounds in the central nervous system (CNS), thanks 7 to a very tight endothelial structure and the action of efflux pumps [1, 2] . Moreover, the drugs 8 available for the treatment of AD are in limited number and are symptomatic drugs associated 9 with unwanted peripheral secondary effects. Finally, considering the number of mechanisms 10 involved in AD progression, delivery of compounds with pleiotropic properties is a promising 11 strategy. For instance, several studies have pointed out that curcumin, a phyto-polyphenol with 12 anti-oxidative, anti-inflammatory activities and low toxicity, could alter several mechanisms 13 involved in AD such as the amyloid-beta cascade, the phosphorylation of Tau protein as well as 14 the development of oxidative stress [3] . However, curcumin brain bioavailability is low due to its 15 poor stability in physiological media [4] and poor permeability across the BBB [5, 6] . 16 Curcumin encapsulation in nanocarriers has been extensively studied for different 17 therapeutic applications, mainly in an effort to by-pass the BBB but also to improve its solubility 18 limitation and chemical instability. Liposomes, micelles, lipids or albumin particles [3, [7] [8] [9] , as 19 well as polyester-based carriers [5, 10] and poly(cyanoacrylate) based carriers [11] have been 20 proposed to deliver curcumin and other substances to the CNS. Curcumin encapsulated in PLGA 21 NPs showed an increased accumulation in CNS tissues compared to free curcumin [12] . 22 Nanoparticle-mediated efficient uptake of active substances into the CNS represents the 23 new field of nanomedecine with great challenge and could represent a major breakthrough in the 24 management of different CNS disorders. Although several proofs of concept have been put 1 forward, the main goal stays elusive, mainly for reasons linked to the dose levels actually 2 delivered, accumulation of polymeric material in the host, more complex cellular environment 3 and interspecies differences between models [13] . Amongst those reasons, one that has been 4 clearly underestimated is the structural properties of the particle. The relationships between the 5 polymer architecture and the resulting NP structural organization are still a matter of debate in 6 spite of several decades of research. In the area of pharmaceutical polymeric nanocarrier, diblock 7 polymers are the most commonly used polymers to form NPs [14, 15] . On the other hand, few 8 systematic studies focusing on establishing the relationship between the polymer architecture and 9 the performances of the nano-carriers in term of encapsulation efficiency, release profile and 10 more generally drug efficacy, are available.
11
The ability of PEGylated NP to penetrate into the brain tissue through the BBB is still a 12 matter of debate. It is well established that drug carriers must be PEGylated in order to circulate 13 for an extended period of time in the blood stream and to provide enough time to the different 14 transport mechanisms to improve NP brain accumulation. "Naked" NPs are usually rapidly 15 opsonized resulting in an increase of liver uptake and macrophage elimination. This strongly 16 decreases their distribution in other organs and tissues, including brain tissues. The influence of 17 PEGylation on the BBB crossing mechanisms is not well documented yet. It has been reported 18 that PEGylated poly(alkylcyanoacrylate) NP penetrate the brain tissues more efficiently than any 19 other nanoformulation using other surface modifications [14, 16] . The specific crossing of a non- [7] . The effect of PEG surface densities and PEG surface organization on BBB crossing 3 efficiency is not well documented. To our knowledge, systematic exploration of these parameters 4 is yet to be conducted.
5
Considering the often opposite properties a NP has to display for a successful clinical 6 outcome [19] , the development of innovative polymer architectures is necessary to maximize the 7 efficacy of delivery to the CNS. We previously developed a library of polymers based on a comb- 8 like architecture exhibiting a backbone of polylactic acid with pendant polyethylene glycol 9 chains. We showed that by systematically varying the amount of PEG in the polymer, we were 10 able to control the NP structure from solid particles to soft, polymer nano-aggregate or "micelle- In this work, we used this library of PEG-g-PLA polymers to prepare nano-vectors loaded 13 with curcumin. The effect of polymer architecture on the structure of the particle, drug 14 encapsulation efficiency, drug loading, the drug release and its modeling taking in account 15 curcumin degradation, were studied. The suitability of these NP for antioxidant delivery was 16 evaluated on a neuronal cell line. This work represents the first step toward the development of 17 an efficient drug delivery system to the CNS. Moreover, our library of NP with a systematic The synthesis of the different polymers used in this study was described elsewhere [20] . 2 Briefly, random copolymerization of D,L-dilactide and benzyl glycidyl ether (BGE) was 3 performed by ring-opening polymerization catalyzed by stannous 2-ethyl hexanoate (SnOct 2 ). 4 The BGE/lactic acid ratio was varied from 0.5 to 3 % to yield PLA chains with different densities 5 of benzyl pendant moities. Alcohol pendant groups were deprotected by catalytic hydrogenation 6 in presence of Pd/Carbon to yield OH-g-PLA. mPEG-COOH (2kD) was grafted onto OH-g-PLA 7 polymers by acylation to yield PEG-g-PLA (polymer A and C in Figure 1 ). Alternatively, the Release studies were carried out in triplicate using the dialysis bag method at 37°C in an block polymer were included to the study in order to better characterised the effect of PEG 4 content and architecture. The polymers' architectures are presented in Figure 1 . The properties of 5 the polymer used in this study are listed in Table 1 . NPs zeta potential was also studied as a function of PEG content in polymer (Fig. 2c) structural differences were noticeable between blank and curcumin-loaded particles (Fig. 3) . curcumin-loaded-NP and blank NP. Noteworthy, the morphology of diblock NP appears more 10 spherical and less polydispersed than particles made from comb polymer of similar PEG content.
Effect of Reactive Oxygen Species (ROS) and reactive nitrogen species (RNS).

11
The dramatic change in size and particle morphology from solid polymeric NPs to soft polymeric 12 aggregates is not only related to polymer PEG content but also to polymer architecture as PEG-b-
13
PLA diblock with PEG content about 6% adopt a soft particle morphology as seen in TEM ( curcumin/polymer ratio for "polymer nano-aggregate" particle made of PEG20%-g-PLA. to 5% for polymer nano-aggregate NPs. As a result, these NPs exhibiting the highest PEG content 3 were found to have the highest values of LE and DL. As shown in Fig. 4 , LE exhibited a plateau 4 before drastically decreasing to values lower than 10 % at 20% w/w curcumin/polymer (Fig. 4a) .
5
At the same time, the DL first increased up to a maximum value, which depends on the polymer 6 PEG content, before decreasing (with the exception of PEG8%-g-PLA (Fig. 4b) . Budhian et al. The NPs ability to encapsulate curcumin was also correlated to NPs hydrodynamic diameter 2 (Fig. 5) . The highest values of LE and DL were obtained for the smallest nanocarriers with a LE 3 of about 50% (Fig. 5a ) and a DL of about 5% (Fig. 5b) . Both LE and DL decrease with the 4 particle size to reach values close to 0% for NPs produced with OH-g-PLA polymer (i.e. PLA 5 chain with hydroxyl branching points along the polymer backbone). Noteworthy, the size of 6 particle is also directly correlated to PEG content. Although curcumin is poorly soluble in PEG, 7 NP PEG content could play a role in LE and DL values. For instance, PLGA nanoparticles 8 prepared with PEO-PPG, an amphiphilic molecule known to cover the surface of the NPs, were 9 shown to be more efficient to encapsulate curcumin than "bare" PLGA NPs [30] . 10 The relationship between polymer architecture, PEG content and encapsulation properties can process, a key factor is the relative rate of precipitation of the hydrophobic drug and the polymer.
22
If the rates of precipitation of the two species are equal, they will form homogeneous particles 23 while large differences between rates will force the selective precipitation of each component and 
Curcumin release and stability studies
14
Release studies were carried out using the same initial curcumin content in NPs over 1 week.
15
Because quantity of encapsulated curcumin in pure PLA NP was so small, it was not possible to 16 dose any release with the detection method used (UV absorbance). This formulation was 17 removed from the release studies. followed trends independently of the PEG content in the NPs (Fig. 5a) In order to quantify curcumin degradation during the release studies, degradation kinetics 4 were quantified in the same media than release studies, at two different concentrations. In these 5 conditions, the degradation kinetics showed a first order degradation rate with a constant k d equal 6 to 0.01h -1 (see Fig. S1 ) and a degradation of 50% after 3 days at 37°C. With the purpose to obtain solubilisation in the polymeric matrix (data not shown). Moreover, encapsulated curcumin has no 1 apparent effect on polymer thermal properties (t g ) and thus their organization within the NPs ( curcumin release without its degradation (Fig. 6c top curve) . Results revealed that the diffusion 3 coefficient in the largest NPs was about 10 times higher than in the smallest NPs (Fig. 6d) . One The PEG content and polymer architecture play a role not only in the determination of NP 18 structure but on drug encapsulation and release. The drug release profiles (Fig 6a and b) and 19 diffusion constants as calculated during release modelling show two regimes, related in part to 20 the size of the NP (Fig 6d) . They are also related to the NP morphologies observed, i.e. solid curcumin-loaded particles ( Fig. 7a and b) . In the presence of hydrogen peroxide (Fig. 7c ), cell 9 survival was reduced by 40% and 20% with blank NPs and Cur-NP, respectively. 10 These results demonstrate that encapsulated curcumin was efficient to protect cells against Practically, an equivalent quantity of drug-loaded NP in blank NP are added for each curcumin 6 concentration levels 7 8 9 In assays involving addition of H 2 O 2 , as expected, an increase in cell mortality (measured 1 by LDH released in the medium) is observed in controls experiments (Fig. 8) . Noteworthy, NP 2 toxicity was not exacerbated by induction of oxidative stress upon addition of H 2 O 2 in the 3 medium (Fig. 8a) . The addition in the media of the blank NP did not affect the release of LDH in 4 the media (Fig. 8a) . This indicates that NP themselves are not able to counteract cell mortality 5 induced by hydrogen peroxide. This is an important control as seemingly non-specific effect of 6 blank NP has been reported and attributed to the properties of NP to carry serum proteins to the 7 cells in culture and induce change in cell proliferation and mortality [37] . 8 On the other hand, curcumin-loaded NP appeared to have a significant effect under the 9 tested conditions (Fig. 8b) , particularly for the di-block NP (5% w/w PEG). However the 10 magnitude of the effect is comparable to free curcumin added to the media (no statistical 11 differences between the groups, p>0.05). 
Reactive Oxygen Species production and inhibitions
13
The direct measurement of intracellular ROS was performed by DCF fluorescence dosage.
14
The control experiments with blank NP show little or no effect on intracellular ROS 15 concentration (Fig. 9a) . No statistically significant scavenging effect was observed for blank 16 particles (upper curves in Fig. 9a ). On the other hand, curcumin-loaded NPs showed a dose-17 response decrease on intracellular ROS levels (Fig. 9b ). At the highest tested concentrations, di-18 block loaded NP and polymer nano-aggregate loaded particles were able to restore ROS level to a 19 level comparable to untreated cells, while loaded solid NPs (PEG8%-g-PLA) appear to be less 20 efficient to counteract the elevation of ROS (Fig. 9b) . The di-block and nano-aggregate NP were 21 found to be as effective as free curcumin, as no statistically significant difference between free 22 curcumin, curcumin-loaded di-block or polymer nano-aggregate particles were found (Fig. 9b ).
23
The difference in effects of each curcumin-loaded NPs batches on ROS levels ( into the NP is only partially released (about 25 to 35% of the dose as seen in Fig. 6a and 6b ), 8 limiting its scavenging effect. Moreover the released content is exposed to degradation in the 9 medium and the cytosol, decreasing the effective dose at a given time point. 10 The polymer architecture controls the drug release (as seen in section 3.4 "Curcumin 11 release and stability studies") and modulates exposure of curcumin to ROS (Fig 9) . generation of intracellular ROS (Fig. 9b) . A minor effect on ROS level is observed for solid NP 25 (NP made from PEG8%-g-PLA) at the higher dose (5µM curcumin or equivalent) as seen on Fig.   1 9a and 9b. This effect on ROS levels is not correlated with cell mortality as shown in Figure 8a 2 and 8b depicting LDH release in the medium and its origin is unknown at this time. . In this study, drug encapsulation and release properties are found to also 8 follow this trend as shown by encapsulation results (Fig. 4) , release profiles ( Fig. 6 ) and notably 9 biological effects (Fig. 9 ). The increase of PEG content is related to an increase in LE (Fig. 4) . 10 On the other side, PEG-b-PLA diblock with a 6% PEG content showed a higher LE than 11 PEG8%-g-PLA comb polymer illustrating the role of architecture. The drug release profiles ( Fig.   12 6a, 6b) and diffusion constants show two regimes, related in part to the size of the NP (Fig. 6d PEG content comb polymers appeared to be the most efficient to reduce oxidative stress (Fig 9) .
20
In this study we have limited our investigation to copolymers of PEG 2kD chains and release properties of the said particles. A structural transition, described previously for several 10 particle properties, located around 15 % PEG content (% w/w) and suggesting a transition 11 from a solid particle regime to a micelle-like behaviour, was also found for release properties properties. This aspect will be address in future studies. PEGylated polymeric particle may also 
